Inventor
ZULLI ALLISON L
US29 patents
⚠️ This page may combine multiple inventors who share the name “ZULLI ALLISON L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CEPHALON INC
7 patentsUS7169802B2Jan 30, 2007
Fused pyrrolocarbazoles
CEPHALON INC18 citations92
US9902696B2Feb 27, 2018
1,4-substituted piperidine derivatives
CEPHALON INC7 citations83
US7241779B2Jul 10, 2007
Fused pyrrolocarbazoles
CEPHALON INC13 citations83
US7671064B2Mar 2, 2010
Fused pyrrolocarbazoles
CEPHALON INC7 citations73
US8044064B2Oct 25, 2011
Fused pyrrolocarbazoles
CEPHALON INC2 citations61
US7514440B2Apr 7, 2009
Fused pyrrolocarbazoles
CEPHALON INC0 citations51
US8383813B2Feb 26, 2013
Fused pyrrolocarbazoles
CEPHALON INC0 citations50
89BIO LTD
6 patentsUS10851057B2Dec 1, 2020
1,4-substituted piperidine derivatives
89BIO LTD5 citations83
US10221135B2Mar 5, 2019
1,4-substituted piperidine derivatives
89BIO LTD7 citations83
US11702388B2Jul 18, 2023
1,4-substituted piperidine derivatives
89BIO LTD3 citations72
US11046707B2Jun 29, 2021
Spiropiperidine derivatives
89BIO LTD4 citations71
US12448392B2Oct 21, 2025
Spiropiperidine derivatives
89BIO LTD0 citations61
US11878982B2Jan 23, 2024
Spiropiperidine derivatives
89BIO LTD0 citations61
BACON EDWARD R
5 patentsUS8673916B2Mar 18, 2014
Methods of treating disorders mediated by histamine H3 receptors using pyridazinone derivatives
BACON EDWARD R7 citations82
US8513232B2Aug 20, 2013
Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands
BACON EDWARD R9 citations82
US8247414B2Aug 21, 2012
Pyridizinone derivatives and the use thereof as H3 inhibitors
BACON EDWARD R2 citations62
US8586588B2Nov 19, 2013
Aryl pyridazinone derivatives and their use as H3 receptor ligands
BACON EDWARD R2 citations61
US8648067B2Feb 11, 2014
Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands
BACON EDWARD R1 citations50
VENATORX PHARMACEUTICALS INC
4 patentsUS10464952B2Nov 5, 2019
Beta-lactamase inhibitors
VENATORX PHARMACEUTICALS INC5 citations72
US12559509B1Feb 24, 2026
Citrate coordination complex of an orally-delivered beta-lactamase inhibitor and uses thereof
VENATORX PHARMACEUTICALS INC0 citations51
US12173018B2Dec 24, 2024
Penicillin-binding protein inhibitors
VENATORX PHARMACEUTICALS INC0 citations50
US11332485B2May 17, 2022
Penicillin-binding protein inhibitors
VENATORX PHARMACEUTICALS INC0 citations50
IGNYTA INC
3 patentsUS9914730B2Mar 13, 2018
Azaquinazoline inhibitors of Atypical protein Kinase C
IGNYTA INC6 citations81
US9896446B2Feb 20, 2018
Azaquinazoline inhibitors of atypical protein kinase C
IGNYTA INC4 citations70
US9914731B2Mar 13, 2018
Pyrazolo[1,5-a]pyridine derivatives and methods of their use
IGNYTA INC0 citations42